News

India`s Aeroflex Industries soars over 81% in debut trade Shares of Indian metallic tubes and hose maker Aeroflex Industries surged as much as 81.8% in trading debut on Thursday, valuing the company at 25.39 billion Indian rupees ($307.14 million). The Mumbai-based firm's share price rose to 196.35 rupees apiece during the session so far, compared to the initial public offer (IPO) price of 108 rupees. The 23.2 million shares allotted to certain investors were subscribed 97.11 times at the end of bidding on Aug. 24, raising 243.50 billion r...
India`s Aeroflex Industries soars over 81% in debut trade
India`s Aeroflex Industries soars over 81% in debut trade
Source: Reuters
31/08/2023 11:58:56 AM
India's Mankind Pharma soars 32% in rare successful market debut BENGALURU  -Shares of India's Mankind Pharma Ltd ended with gains of 31.7% in their trading debut on Tuesday, valuing the maker of Manforce condoms at 569.76 billion rupees ($6.97 billion) in a rare instance of a successful domestic public listing this year. Mankind's 43.26 billion rupees initial public offering (IPO) ranks as India's biggest so far in 2023, and the third-biggest ever. It is also the biggest among Indian pharma companies since Gland Pharma Ltd went public ...
India's Mankind Pharma soars 32% in rare successful market debut
India's Mankind Pharma soars 32% in rare successful market debut
Source: Reuters
9/05/2023 7:44:53 PM
View on Mankind Pharma IPO from S Ranganathan, LKP Securities Below is View on Mankind Pharma IPO by S Ranganathan, Head of Research at LKP Securities   Fast Growing India Centric Mankind Pharma truly deserves credit for bringing back life into the Primary Market during CY 2023 with a stellar listing which provided a 30% return to Retail Investors and the icing on the cake was the allotment itself wherein almost all retail investors were allotted the shares.   Above views are of the author and not of the website kindly read di...
View on Mankind Pharma IPO from S Ranganathan, LKP Securities
View on Mankind Pharma IPO from S Ranganathan, LKP Securities
Source: LKP Securities Ltd
9/05/2023 12:36:46 PM
Quote on Mankind Pharma listing by Mr. Hemang Jani, Motilal Oswal Financial Services Ltd Below is Mankind Pharma listing by Mr. Hemang Jani, Head Equity Strategy, Motilal Oswal Financial Services   “Mankind Pharma got listed at 20% premium to the IPO price, thus receiving a strong response. The primary market saw an IPO hitting after a long gap, thus the interest was high. Moreover the healthcare sector was a laggard over last one year but started seeing traction over last two months as the monthly pharma data showed improvement. Thus Mankind Pharma received...
Quote on Mankind Pharma listing by Mr. Hemang Jani, Motilal Oswal Financial Services Ltd
Quote on Mankind Pharma listing by Mr. Hemang Jani, Motilal Oswal Financial Services Ltd
Source: Motilal Oswal Financial Services Ltd
9/05/2023 11:51:16 AM
Mankind Pharma lists with 20.37% premium on the BSE Mankind Pharma has debuted at Rs 1300.00 on the BSE, up by 220 points or 20.37% from its issue price of Rs 1080. The scrip is currently trading at Rs 1388.30, up by 308.30 points or 28.55% from its issue price. It has touched a high and low of Rs 1395.00 and Rs 1300.00 respectively. So far 7.19 lakh shares were traded on the counter. The offering, which was open for subscription between April 25, 2023 and April 27, 2023 was subscribed over 15 times. The issue price was fixed at Rs 1080 ...
Mankind Pharma lists with 20.37% premium on the BSE
Mankind Pharma lists with 20.37% premium on the BSE
Source: Accord Fintech
9/05/2023 11:33:27 AM
Condom maker Mankind up 23% in India`s biggest listing of 2023 Shares of Manforce condom maker Mankind Pharma Ltd surged as much as 23% in debut trading on Tuesday, valuing the company at 531.58 billion rupees ($6.50 billion), and making it the biggest domestic listing so far this year. The company, which also owns at-home pregnancy testing kit Prega News, opened at 1,300 rupees, compared with an offer price of 1,080 rupees for its initial public offering. Indian benchmark indexes, the Nifty 50 and the S&P BSE Sensex, were up 0.3% each as of 10...
Condom maker Mankind up 23% in India`s biggest listing of 2023
Condom maker Mankind up 23% in India`s biggest listing of 2023
Source: Reuters
9/05/2023 10:21:44 AM
IPO Note : Mankind Pharma Ltd By Geojit Financial Services Leading domestic pharma player with diverse product portfolio KEY CHANGES: TARGET Mankind Pharma Ltd (MPL) is the fourth largest pharmaceutical company in India by domestic sales and third largest by sales volume. With 97% of its revenue from India, MPL sells pharmaceutical formulations and consumer healthcare goods, and operates 25 manufacturing sites and a specialised R&D centre with four divisions. • The size of the Indian pharmaceutical market (IPM) was ?1,859 billion in FY...
IPO Note : Mankind Pharma Ltd By Geojit Financial Services
IPO Note : Mankind Pharma Ltd By Geojit Financial Services
Source: Geojit Financial Services Ltd
24/04/2023 2:12:37 PM
IPO Note : Mankind Pharma By Anand Rathi Share and Stock Brokers All set for strong differentiation pipeline. Being the second company to launch Dydroboon (Rs1.5bn sales in FY22), Mankind plans to develop and launch such new chemical entities. GPR119, an anti-diabetic molecule is in phase-I clinical trials. The company is on track to developing several antiallergic and anti-cancer biosimilars. Focus on acquisitions, expanding its chronic therapies. Sales of chronic therapies (33% of FY22 revenues) clocked an 18% CAGR over FY20-22, outpacing the IPM&rsqu...
IPO Note : Mankind Pharma By Anand Rathi Share and Stock Brokers
IPO Note : Mankind Pharma By Anand Rathi Share and Stock Brokers
Source: Anand Rathi Shares and Stock Brokers
24/04/2023 1:57:31 PM
Mankind Pharma announces launch of initial public offering Mankind Pharma Ltd. has announced public offering of 40058844 shares at a price of Rs 1.00 each for Cash at a Premium of Rs 1,079.00 per share. The gross proceeds of the issue are expected to be Rs 4,32,635.52 lakhs. The company's initial public offer (IPO) will open on 25 April 2023 and is expected to close on 27 April 2023, subject to customary closing conditions. The price band of the issue has been fixed at Rs 1,026.00-1,080.00 per share. The IPO includes a fresh Issue of 40058844 ...
Mankind Pharma announces launch of initial public offering
Mankind Pharma announces launch of initial public offering
Source: Dion Global Services Ltd
20/04/2023 4:54:09 PM
India`s Mankind Pharma sets IPO price band of 1,026 to 1,080 rupees a share  Indian pharmaceutical company Mankind Pharma Ltd has set a price band of 1,026 rupees to 1,080 rupees per share for its initial public offering (IPO), according to a newspaper advertisement, valuing the company at 432.64 billion rupees ($5.27 billion) at the upper end of the band. The IPO for the company, which owns the Manforce condom brand and pregnancy testing kit Prega News, will consist of nearly 40.1 million shares on offer for sale from existing shareholders, according to a dr...
India`s Mankind Pharma sets IPO price band of 1,026 to 1,080 rupees a share
India`s Mankind Pharma sets IPO price band of 1,026 to 1,080 rupees a share
Source: Reuters
19/04/2023 10:11:56 AM
India's Mankind Pharma files for IPO Indian pharmaceutical company Mankind Pharma Ltd has filed draft papers for an initial public offering (IPO) with the domestic market regulator. The IPO will consist of 40.1 million shares on offer for sale from existing shareholders, according to the draft prospectus dated Sept. 15.
India's Mankind Pharma files for IPO
India's Mankind Pharma files for IPO
Source: Reuters
16/09/2022 2:30:17 PM
Key News - HDFC Bank, Vodafone Group , Mankind Pharma, IndiGo By ARETE Securities Key News HDFC twins merge in $40-bn deal; amalgamation may take 15 to 18 months A merger, which was in the making for years, has finally fructified in a $40- billion deal to create a banking behemoth. The country’s largest housing finance company and the biggest private sector bank announced on Monday that their boards have approved an all-stock amalgamation of HDFC Ltd into HDFC Bank, subject to regulatory approvals. At present, HDFC is the parent company of the bank. The merg...
Key News - HDFC Bank, Vodafone Group , Mankind Pharma, IndiGo By ARETE Securities
Key News - HDFC Bank, Vodafone Group , Mankind Pharma, IndiGo By ARETE Securities
Source: ARETE Securities Ltd
5/04/2022 10:06:26 AM
Key News - GAIL, Life Insurance Corporation ,Mankind Pharma, Moody's Investors Service By ARETE Securities Key News GAIL to connect Srinagar to gas grid; Mumbai-Nagpur line by May 2023 State-owned GAIL India Ltd plans to lay a pipeline to Srinagar to take the environmentally friendly natural gas to the Kashmir Valley as it doubles down on efforts to expand infrastructure to helm the government vision of a gas-based economy, its chairman and managing director Manoj Jain said. GAIL will by May 2023 complete a 700-km pipeline from Mumbai to Nagpur, enabling the flow of gas to central India a...
Key News - GAIL, Life Insurance Corporation ,Mankind Pharma, Moody's Investors Service By ARETE Securities
Key News - GAIL, Life Insurance Corporation ,Mankind Pharma, Moody's Investors Service By ARETE Securities
Source: ARETE Securities Ltd
17/02/2022 9:13:57 AM
Key News - Adani Ports and Special Economic Zone Ltd, Tech Mahindra Ltd, Tata group, Mankind Pharma Ltd, Maruti Suzuki By ARETE Securities Key News Adani Ports Q3 net profit declines 6% to Rs 1,478.76 cr, revenue flat Adani Ports and Special Economic Zone Limited (APSEZ) on Tuesday reported a 6.20 per cent decline in consolidated profit at Rs 1,478.76 crore for the third quarter ended December 2021. The country's largest integrated logistics player had clocked a consolidated profit of Rs 1,576.53 crore in the corresponding period a year earlier, according to a regulatory filing. Its total consolidated income increased ...
Key News - Adani Ports and Special Economic Zone Ltd, Tech Mahindra Ltd, Tata group, Mankind Pharma Ltd, Maruti Suzuki By ARETE Securities
Key News - Adani Ports and Special Economic Zone Ltd, Tech Mahindra Ltd, Tata group, Mankind Pharma Ltd, Maruti Suzuki By ARETE Securities
Source: ARETE Securities Ltd
2/02/2022 9:51:22 AM
Accenture accelerates Mankind Pharma`s digital transformation Mankind Pharma, the fourth largest pharmaceutical manufacturing company headquartered in India, has collaborated with Accenture to accelerate its digital transformation journey to become an intelligent enterprise, improving business agility, performance, and operational efficiency. Accenture has redesigned the pharma major's business processes across key functions such as finance, supply chain, sales and procurement for better inventory optimisation, demand planning, workforce producti...
Accenture accelerates Mankind Pharma`s digital transformation
Accenture accelerates Mankind Pharma`s digital transformation
Source: IANS
3/05/2021 4:47:49 PM